DMI-Logo
search-iconsearch-icon

Others Research Reports & Consulting

Home
>
Reports
>
Pharmaceuticals
>
Others
Browse reports
DataM has exclusive market relevance and knowledge catering our services in 60+ industries
SUB CATEGORIES
All PharmaceuticalsCardiovascularCentral Nervous SystemDermatologyEar Nose Throat DisordersGastrointestinalGenitourinary DisordersHematologyHormonal DisordersImmunologyInfectious DiseaseMetabolic DisorderDiabetes CareMouth And Dental DisordersPain ManagementMusculoskeletalNeurologyNon-Malignant DisordersNutritional DisordersOncologyOphthalmologyOther DiseasesAllergyRespiratoryWomen's and Male HealthWound Care TreatmentSyndromeOthers
FILTER
Geography
Publish Date
Themesdown
SORT
Upload Date
Upload Date
Price
Published: 2024 October 09
Hypofibrinogenemia Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Hypofibrinogenemia Market is estimated to grow at a high CAGR during the forecast period 2024-2031
Starting from
$4350$2999
Published: 2026 September 22
Giant Cell Arteritis Drugs Market Trends, Competitive Landscape and Forecast, 2026–2035
The giant cell arteritis drugs market is valued at USD 1.11 billion in 2025 and is forecast to reach USD 2.62 billion by 2035, expanding at a 9.0% CAGR during 2026–2035. Explore treatment, route, channel and regional trends.
Starting from
$4350$2999
Published: 2025 May 12
Chronic Inflammatory Demyelinating Polyneuropathy Market Size, Share, Industry, Forecast and outlook (2025-2033)
The global chronic inflammatory demyelinating polyneuropathy market size reached US$ 2.02 Billion in 2024 and is expected to reach US$ 5.07 Billion by 2033
Starting from
$4350$2999
Published: 2026 January 07
Cushing's Syndrome Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Global Cushing’s syndrome market reached US$ 146.5 million in 2023 and is expected to reach US$ 291.1 million by 2031
Starting from
$4350$2999
Published: 2024 June 24
Polymyositis Drugs Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Polymyositis Drugs Market is expected to reach a CAGR of YY% By 2031: DataM Intelligence
Starting from
$4350$2999
Published: 2026 January 12
Lymphedema Treatment Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Lymphedema Treatment Market analysis including size, CAGR forecasts, key players, treatment types, regional share, growth drivers and challenges to 2035.
Starting from
$4350$2999
Published: 2025 August 22
Turner Syndrome Market Size, Share, Industry, Forecast and Outlook (2025-2033)
The global turner syndrome market will grow from USD 2.34 billion in 2024 to USD 4.22 billion by 2033, at a CAGR of 6.8% (2025–2033).
Starting from
$4350$2999
Published: 2026 January 07
Post-Bariatric Hypoglycemia Market Size, Share, Industry, Forecast and outlook (2024-2031)
The Post-Bariatric Hypoglycemia Market is expected to reach at a CAGR of 6.5% during the forecast period 2024-2031 | DataM Intelligence
Starting from
$4350$2999
Published: 2026 September 04
Exocrine Pancreatic Insufficiency Treatment Market Size, Share, Industry, Forecast and Outlook (2026-2033)
Exocrine Pancreatic Insufficiency Treatment Market size was at US$ 3.72 billion in 2025 and is expected to reach US$ 6.05 billion by 2033, growing at a CAGR of 6.4%.
Starting from
$4350$2999
Published: 2026 August 20
Oncology Clinical Trials Market Size, Share, Industry, Forecast and Outlook (2026-2035)
Global Oncology Clinical Trials Market reached US$ 19.73 billion in 2024 , growing at a CAGR of YY% during the forecast period 2026-2033.
Starting from
$4350$2999